摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲氧基-[1,1-联苯]-4-羧酸甲酯 | 175152-70-2

中文名称
3-甲氧基-[1,1-联苯]-4-羧酸甲酯
中文别名
——
英文名称
methyl 3-methoxy-[1,1'-biphenyl]-4-carboxylate
英文别名
methyl 2-methoxy-4-phenylbenzoate
3-甲氧基-[1,1-联苯]-4-羧酸甲酯化学式
CAS
175152-70-2
化学式
C15H14O3
mdl
——
分子量
242.274
InChiKey
UGDRDPIUCCRDNA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    45-47 °C
  • 沸点:
    372.3±30.0 °C(Predicted)
  • 密度:
    1.118±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2922299090

SDS

SDS:c2edafb4f7a2be4aa4ceaf44542a9825
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Methyl 3-methoxybiphenyl-4-carboxylate
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-methoxybiphenyl-4-carboxylate
CAS number: 175152-70-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C15H14O3
Molecular weight: 242.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-甲氧基-[1,1-联苯]-4-羧酸甲酯吡啶 、 palladium diacetate 、 三氯化硼caesium carbonate2-二环己基磷-2,4,6-三异丙基联苯 作用下, 以 二氯甲烷甲苯 为溶剂, 反应 11.0h, 生成
    参考文献:
    名称:
    优化第二代Ac啶酮作为广谱抗疟药。
    摘要:
    尽管为消灭疟疾付出了巨大的努力,但疟疾对全球的影响仍然惊人。随着耐药性的增加和缺乏临床上可用的疫苗,迫切需要用于预防和治疗疟疾的新颖,可负担和安全的药物。以前,我们描述了一种新型的抗疟疾cri啶酮化学型,可有效对抗血液阶段和肝脏阶段的疟原虫。在这里,我们描述了一个优化的过程,该过程已产生了第二代cri啶酮系列,其功效,代谢稳定性,药代动力学和安全性均得到了显着改善。这些发现突出了双阶段靶向a啶酮作为进一步临床前开发的新药候选物的治疗潜力。
    DOI:
    10.1021/acs.jmedchem.0c00539
  • 作为产物:
    描述:
    C15H16O4 在 [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2 作用下, 以 1,2-二氯乙烷 为溶剂, 生成 3-甲氧基-[1,1-联苯]-4-羧酸甲酯
    参考文献:
    名称:
    Ru 催化乙烯基氧化亚叶立德与缺电子炔烃和烯烃的苯并环化反应
    摘要:
    在此,我们报道了卡宾介导的乙烯基亚砜叶立德与缺电子炔烃和烯烃的苯并环化反应以合成含氧芳烃。该方案具有出色的区域选择性、广泛的底物范围和温和的反应条件。机理研究表明,该反应通过呋喃生成、环加成、环裂解和芳构化级联进行。合成的芳烃已被用于多种产品转化和芳烃环同系化。
    DOI:
    10.1021/acs.orglett.2c03388
点击查看最新优质反应信息

文献信息

  • [EN] ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-I' PATHWAY AND METHODS OF USE THEREOF<br/>[FR] ACTIVATEURS DE LA VOIE DU GÈNE INDUCTIBLE PAR L'ACIDE RÉTINOÏQUE "RIG-I" ET LEURS PROCÉDÉS D'UTILISATION
    申请人:KINETA INC
    公开号:WO2020036574A1
    公开(公告)日:2020-02-20
    The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.
    本发明涉及式(I)化合物,该化合物是RIG-I通路的激活剂。
  • ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-I" PATHWAY AND METHODS OF USE THEREOF
    申请人:Kineta Immuno-Oncology LLC
    公开号:US20200055871A1
    公开(公告)日:2020-02-20
    The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.
    本发明涉及式(I)化合物,该化合物是RIG-I通路的激活剂。
  • [EN] ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-1" PATHWAY AND METHODS OF USE THEREOF<br/>[FR] ACTIVATEURS DE LA VOIE DU GÈNE INDUCTIBLE PAR L'ACIDE RÉTINOÏQUE "RIG-1" ET LEURS PROCÉDÉS D'UTILISATION
    申请人:KINETA INC
    公开号:WO2020033782A1
    公开(公告)日:2020-02-13
    The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.
    本发明涉及式(I)化合物,该化合物是RIG-I通路的激活剂。
  • Benzoheterocyclic derivatives
    申请人:Otsuka Pharmaceuticals Co., Ltd.
    公开号:US06335327B1
    公开(公告)日:2002-01-01
    A benzoheterocyclic derivative of the following formula [1]: and pharmaceutically acceptable salts thereof, which show excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as a vasopressin antagonist, vasopressin agonist or oxytocin antagonist.
    以下是该句子的中文翻译: 一种苯并杂环衍生物,其化学式如下: 及其药用盐,表现出优异的抗加压素活性、加压素激动活性和催产素拮抗活性,可用作加压素拮抗剂、加压素激动剂或催产素拮抗剂。
  • THIAZEPINE DERIVATIVE
    申请人:Daiichi Sankyo Company, Limited
    公开号:EP2119719A1
    公开(公告)日:2009-11-18
    The present invention relates to a thiazepine derivative or a pharmacologically acceptable salt thereof having an excellent effect of inhibiting 11β-hydroxysteroid dehydrogenase type 1. A thiazepine derivative or a pharmacologically acceptable salt thereof having general formula (I): wherein R1 represents a hydrogen atom, a C1-C6 alkyl group or the like; R2 represents a C1-C6 alkyl group, a C1-C6 halogenated alkyl group, a C1-C6 hydroxyalkyl group, or the like; R3 represents a hydrogen atom or a C1-C6 alkyl group; R4 represents a C6-C10 aryl group that may be substituted with 1 to 5 group(s) independently selected from Substituent Group a or a heterocyclic group that may be substituted with 1 to 3 group(s) independently selected from Substituent Group a; Substituent Group a consists of a halogen atom, a C1-C6 alkyl group, a C6-C10 aryl group that may be substituted with 1 to 5 group(s) independently selected from Substituent Group b, and so forth; Substituent Group b consists of a halogen atom, a C1-C6 alkyl group, a C1-C6 halogenated alkyl group, and so forth.
    本发明涉及一种噻吩啶衍生物或其药理学上可接受的盐,具有优异的抑制11β-羟基类固醇脱氢酶1型的作用。具有通式(I)的噻吩啶衍生物或其药理学上可接受的盐: 其中 R1代表氢原子、C1-C6烷基或类似物;R2代表C1-C6烷基、C1-C6卤代烷基、C1-C6羟基烷基或类似物;R3代表氢原子或C1-C6烷基;R4代表可能被1至5个独立选择自取代基团a的基团取代的C6-C10芳基,或可能被1至3个独立选择自取代基团a的基团取代的杂环基团;取代基团a由卤原子、C1-C6烷基、可能被1至5个独立选择自取代基团b的基团取代的C6-C10芳基等组成;取代基团b由卤原子、C1-C6烷基、C1-C6卤代烷基等组成。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐